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Oxidase assemblyRespiration in plants, most animals and many aerobic microbes is dependent on heme A. This is a highly
specialized type of heme found as prosthetic group in cytochrome a-containing respiratory oxidases. Heme A
differs structurally from heme B (protoheme IX) by the presence of a hydroxyethylfarnesyl group instead of a
vinyl side group at the C2 position and a formyl group instead of a methyl side group at position C8 of the
porphyrin macrocycle. Heme A synthase catalyzes the formation of the formyl side group and is a poorly
understood heme-containing membrane bound atypical monooxygenase. This review presents our current
understanding of heme A synthesis at the molecular level in mitochondria and aerobic bacteria. This article is
part of a Special Issue entitled: Biogenesis/Assembly of Respiratory Enzyme Complexes.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Heme A is essential for respiration in a wide range of different
organisms including bacteria, archaea, plants and animals. This iron
porphyrin compound is prosthetic group of cytochrome a in the
terminal enzyme of the respiratory chain where dioxygen is reduced
to water with the concomitant conservation of the energy released in
the reaction to form an electrochemical transmembrane gradient.
Biosynthesis of heme A comprises the chemically demanding conver-
sion of one speciﬁc methyl side group, out of four possible ones, on
heme, into a formyl group. This reaction is catalyzed byhemeA synthase
(HAS), an as yet little understood membrane-bound enzyme. Reasons
for taking interest in heme A biosynthesis are the biological importance
of heme A and the reaction mechanism of HAS. Detailed knowledge
about heme A biosynthesis also contributes to our understanding of
assembly of respiratory oxidases and of human diseases associated with
mutations in the gene for HAS. In addition, heme A biosynthesis is a
potential target for new antimicrobial drugs, e.g. against Staphylococcus
aureus [1]. Finally, heme A and chlorophyll b biosynthesis show similar
molecular features suggesting that insight into one of these processes
will help to better understand also the other process., heme A synthase; HOS, heme
nesis/Assembly of Respiratory
rsity Sölvegatan 35, SE-223 62
24113.
l rights reserved.This review ﬁrst presents the molecular properties and biological
function of heme A. Subsequently the heme A biosynthetic pathway
and the central enzyme HAS are presented in the details. This
includes properties of heme A deﬁcient cells and organisms, the
chemical composition of HAS and a compilation of experimental
ﬁndings obtained so far with wild-type and mutant enzyme variants.
Heme A and chlorophyllide b biosynthesis are then compared. Finally
is presented some fundamental open questions concerning heme A
and its biosynthesis.
2. Structure and properties of heme A
Heme A is a derivative of protoheme IX (heme B) with a formyl
group at position C8 and a hydroxyethylfarnesyl (in most cases; see
below) group at position C2 on the porphyrin macrocycle (Fig. 1).
Heme B, the prosthetic group of most heme-proteins including for
example cytochrome b and hemoglobins, has a C8 methyl group and a
C2 vinyl group. The electron-withdrawing formyl group, as opposed
to the methyl group, affects the redox, spectral and ligand-binding
properties of the heme.
HemeO, present as prosthetic group in some terminal oxidases such
as Escherichia coli cytochrome bo3, is hydroxyethylprenylated like heme
A but has, like heme B, a C8methyl group. Variants of hemeA and heme
O with an ethenylfarnesyl, ethenylgeranylgeranyl or hydroxygeranyl-
geranyl C2 side chain are found in organisms belonging to the Archaea
domain [2]. For example, the extremely thermophilic Aeropyrum pernix
and species of Sulfolobus contain heme A (heme AS) with a hydro-
xyethylgernaylgeranyl side group [2,3]. Except for the case of heme A,
heme with a formyl group is rare in nature. Among the few examples
are spirographis heme (2-formyl-4-vinyldeuteroheme) of unknown
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substituted heme found in myeloperoxidase of polymorphogenic
leukocytes [6].
Heme A, as compared to isolated heme B, has a higher midpoint
redox potential and the light absorption maxima shifted to longer
wavelengths. The reduced pyridine hemochromogen spectrum, for
example, of heme B and heme A shows the alpha-band absorption
peak at 556 and 585 nm, respectively [7]. The formyl group of heme
A is prone to oxidation to a carboxyl group rendering heme A
somewhat unstable after extraction from biological material. Heme B
is an amphiphilic molecule, poorly soluble as monomer in aqueous
solutions at neutral pH. The prenyl side chain of hemes A and O
makes these heme variants even more lipophilic than heme B. Heme
is rather toxic to cells due to its detergent-like property and because
the iron atom of reduced heme in the presence of molecular oxygen
can generate reactive oxygen species cf [8]. Inside the cells, heme
must be transported and stored in such a way that toxic effects are
minimized.
3. Heme A as prosthetic group
Heme A was discovered by Warburg and Gewitz [9] and ﬁrst
isolated in 1962 from bovine heart muscle [10]. Its chemical structure
was established in 1975 [11] and conﬁrmed by X-ray crystallography
in 2005 when also the absolute conﬁguration of the hydroxyethyl-
farnesyl group was determined [12]. Despite the vast importance and
wide distribution among organisms, heme A is of low abundance in
nature compared to many other types of heme. Heme A is only found
in aerobic organisms and as prosthetic group in only one class of
proteins, namely the cytochrome a-containing respiratory oxidases.
Members of the family of heme–copper oxidases function as terminal
enzyme in aerobic respiration in microbes, plants and animals.
Cytochrome aa3 of mammalian mitochondria (also known as cyto-
chrome c oxidase and Complex IV) and that of the bacteria Paracoccus
denitriﬁcans and Rhodobacter sphaeroides is known in molecular details
and serve well as paradigm for this family of respiratory oxidases [13].
The enzyme contains two heme A molecules as prosthetic groups
designated heme a and heme a3 by the cytochrome pioneers Keilin and
Hartree based on the observed different reactivity of the two hemes to
added ligands [14]. Heme a3 and a copper atom (CuB) constitute part of
the active site where the four electron reduction of dioxygen to water
takes place. Heme a is the direct electron donor to the active site and is
in turn reduced by a dicopper center (CuA). Heme-copper respiratory
oxidases are multi-protein membrane bound enzymes with a variable
number of polypeptides but have a conserved core of three differentHO
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Fig. 1. Structure of heme B and heme A. Protoporphyrin IX carbon atoms 2 and
8 according to Fisher's nomenclature are indicated.subunits. Both hemes and CuB are ligated to Subunit I whereas CuA is
bound to Subunit II.
The 2.8 Å x-ray crystal structure of the 13 protein subunit bovine
cytochrome c oxidase [15,16] shows the two heme A molecules
positioned close to each other in the membrane spanning part of
Subunit I. Both hemeplanes have a perpendicular orientation relative to
the membrane plane and are in a 104° angle. The iron to iron distance
between the hemes is about 14 Å. Heme a is hexa-coordinatedwith the
imidazole groups of two histidine residues (His-61 on helix I and His-
378 on helix X) as axial ligands to the iron atom. Heme a3 is penta-
coordinated (one coordination site is open for dioxygen binding) with
His-376 (on helix X) as the distal ligand to the iron atom. The
hydroxyethylfarnesyl chain of heme a has an extended conformation
and is in contact with helices I, II, X, XI and XII of subunit I. The
corresponding chain of heme a3 is twisted and located between helices
VIII and IX. All hydrophilic side groups of the two heme molecules are
hydrogen-bonded to protein residues. The formyl group of heme a is
hydrogen bonded to an arginine residue (Arg38) that is conserved in
heme A-containing cytochrome c oxidases and has role in discrimina-
tion between heme A and heme O or heme B [17]. Interestingly, the
hydroxyl group of the hydroxyethylfarnesylmoiety is hydrogen bonded
to Ser328 in oxidized bovine cytochrome c oxidase but to Ser34 in the
reduced enzyme [18].
The basic biophysical properties of heme A bound to protein have
elegantly been investigated using synthetic four-helix bundle pro-
teins, called maquettes [19,20]. Using such a cytochrome mimic,
containing the histidine analog (3-methyl-L-histidine), and various
hemes it was demonstrated that the formyl group of heme A results
in a 179 mV positive shift in the redox potential due to destabilization
of ferric heme binding to the maquette relative to ferrous heme
binding. The hydroxyethylfarnesyl chain, in contrast, stabilizes the
binding of both ferrous and ferric hemes to the maquette by at least
6.3 kcal/mol but does not signiﬁcantly affect the redox potential of
the heme compared to heme B. This increased binding due to
hydrophobic interaction between the heme and protein seemingly
counteracts the destabilizing effect of the formyl group [19].
Heme A is in principle not required for function of proton-pumping
heme–copper respiratory oxidases. For example, in E. coli cytochrome bo3
hemes B and O occupy the positions corresponding to those for heme a
and heme a3 inmammalian cytochrome aa3 [21]. There are also bacterial
cytochrome ba3 enzymes containing heme B in the electron donor site
[22] and heme A at the active site as well as cytochrome cbb3 heme–
copper oxidases [23]. The two heme groups are positioned similarly in
Subunit I in these oxidases but there are structural differences depending
on the type of heme in each site. At least some bacterial oxidases are
promiscuous being able to incorporate heme B or heme O instead of
heme A. Misincorporation of heme B or heme O instead of heme A into
heme–copper oxidase is promoted by some mutations [17,24] and by
oxygen-limitation during growth of the microorganism [25,26]. Recipro-
cally, E. coli cytochrome bo3 has been observed tomisincorporate hemeA
(into the heme O site) when expressed in P. denitriﬁcans [27]. Heme-
substitution in oxidases generally seems to negatively affect enzyme
activity.
4. Overview of heme A biosynthesis
The heme A biosynthetic pathway from heme B involves two
membrane bound enzymes and has heme O as one stable protein
dissociable intermediate. The modiﬁcation of the C2 vinyl group of
heme B into the hydroxylethylfarnesyl group is catalyzed by heme O
synthase (HOS) with farnesylpyrophosphate as co-substrate. The
subsequent monooxygenation of the C8 methyl group to yield heme
A is catalyzed by HAS and requires molecular oxygen (Fig. 2). This
biosynthetic reaction and the enzyme protein involved were
originally discovered by the use of metabolic labeling and mutants
impaired in heme A synthesis [28]. In pioneering work, Sinclair et al.
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that heme A is synthesized from heme B [29]. This was subsequently
conﬁrmed using a Bacillus subtilis ferrochelatase-deﬁcient mutant
[30]. In 1974 Taber demonstrated that certain sporulation-deﬁcient
isolates of B. subtilis, with a mutation in a gene later identiﬁed and
named ctaA, are cytochrome a-defective [31,32]. Viability of aerobic
bacterial cytochrome a-deﬁcient mutants is explained by the
presence of a branched respiratory chain with a heme A-
independent terminal oxidase, cytochrome bd. Heme O is normally
not found at detectable levels in B. subtilis cells but can accumulate if
the ctaA gene is inactivated. This ﬁnding by Svensson et al. in 1993,
combined with their observation that E. coli cells containing the B.
subtilis CtaA protein produce heme A (E. coli is able to synthesize
heme O but not heme A), established CtaA as HAS [33]. The cyoE gene
of the cyoABCDE operon in E. coli had previously been identiﬁed to
encode HOS [34]. Based on sequence comparisons with CyoE and
biochemical analysis of mutants, B. subtilis CtaB (as well as the
paralogue CtaO [35]), P. denitriﬁcans CtaB and Saccharomyces
cerevisiae COX10p, were identiﬁed as HOS [28].
5. Heme A synthase (HAS)
5.1. Amino acid sequence and evolution
HAS in most organisms consists of a single polypeptide of some
300 amino acid residues. In silico primary sequence analysis [36,37]
and topology studies with B. subtilis CtaA using fusions to alkaline
phosphatase [38] indicate that the enzyme protein has 8 transmem-
brane segments (TM I–IIX) with both the N- and C-termini exposed
on the negative side of the membrane (Fig. 3.), i.e., to the cytoplasm in
bacteria and matrix in mitochondria. Some organisms belonging to
the Archaea evolutionary domain contain a shorter HAS polypeptide
variant of about 160 residues and only 4 TMs. This type, found
for example in the hyperthermophile A. pernix and the halophile
Halobacterium salinarium, is called compact CtaA (cCtaA) [39]. cCtaA
polypeptides form functional homo-dimers corresponding in size and
topology to the 8 TM HAS polypeptides. The 8 TM protein-type seems
to originate from a primordial 4 TM variant by a tandem gene
duplication event followed by gene fusion and subsequent divergent
evolution of the N- and C-terminal halves of the polypeptide [39]. The
amino acid sequences of HAS from distantly related organisms show
relatively poor conservation but homology between the N- and C-
terminal halves of the protein can generally be observed [36]. Possibly
each half forms a four-helix bundle domain. Among the few
conserved amino acid residues in HAS are four His (here denoted as
H1, H2, H3 and H4; Fig. 3.). H1 is replaced by an Asp in bacteria
belonging to Actinomycetales [37]. Two hydrophilic peptide loops,
connecting TM I with II and TM V with VI, respectively, are predictedHHO HO
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Fig. 2. Heme A biosynthetic pathway from heme O. All three reaction steps are proposed
resulting in a germinal diol that in step 3 is dehydrated resulting in the formyl group.to be exposed on the positive side of the membrane. The sequence of
the TM I–II loop is more conserved than that of the TM V–VI loop and
contains in bacteria two invariant Cys residues here denoted as C1
and C2. HAS of Bacillus species contains two additional invariant Cys
(C3 and C4) in the TM V–VI loop (Fig. 3).5.2. Chemical composition of bacterial HAS
Published experimental data for HAS isolated fromdifferent bacteria
is summarized in Table 1. The B. subtilis HAS (CtaA) has been studied
most extensively and analyzed in situ in isolated membranes [36] and
after solubilization and puriﬁcation in the presence of non-ionic
detergents. Wild-type, not tagged, as well as hexa-histidyl tagged (N-
or C-terminal) CtaA variants has been isolated (Table 1). It is important
to note that all published in vitro biochemical data concerning HAS is
based on the protein produced by over-expression of the cloned
structural gene in the homologous organism (the case of B. subtilis) or
heterologously in E. coli.
Isolated bacterial HAS preparations contain heme B. Depending on
the protein variant and the conditions under which the protein was
synthesized before puriﬁcation, preparations of HAS usually contain
also heme O or derivatives of heme O including the enzyme product,
heme A (Table 1). It is assumed that heme B acts as prosthetic group
and that heme A, when present, is enzyme product remaining bound to
HAS because a limiting number of acceptor proteins, such as heme A
trafﬁcking proteins or Subunit I apo-protein, is present. From available
data it cannot be completely ruled out that the heme B found in HAS is
an experimental artifact resulting from the overproduction of the
protein.Metal and spectroscopic analyses of isolatedHAS indicate heme
as the single kind of prosthetic group; no signiﬁcant amounts of non-
heme iron nor copper have been detected in B. subtilis CtaA produced in
B. subtilis [40].
B. subtilis HAS has been found to contain between 0.2 and 1.95 mol
heme B per mol CtaA polypeptide and up to≤0.2 mol heme A per mol
CtaA (Table 1). The presence of heme A in CtaA is promoted by
aeration of the culture and level of CtaB/heme O in the cell [40]. Low
oxygen conditions cause accumulation on HAS of heme O (enzyme
substrate) or heme I (ﬁrst reaction intermediate) instead of heme A
[41]. As judged from visible light absorption spectra of membrane
bound and detergent-solubilized CtaA the heme binding properties
are the same for B. subtilis HAS produced in E. coli as in B. subtilis. HAS
of bacteria shows the features of a cytochrome of relatively high
redox potential (Table 2). The iron atom of heme B, and also of heme
A when present in HAS, is low spin and apparently hexa-coordinated
[40]. EPR signals of heme A and heme B in oxidized isolated B. subtilis
HAS are highly anisotropic with gmax≥3.5 (Table 2) suggesting bis-
His or His-Met heme iron axial ligation [42].HOO
Fe
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N NO
H
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H
3
COOH COOHCOOH COOH
Heme A
to occur on the HAS enzyme. Steps 1 and 2 are successive monooxygenase reactions
A B
C1 C1C3
C4C2 C2
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I III IIIII IIIIV IVV VI VII VIII
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Fig. 3.Membrane topology models of CtaA from B. subtilis (A) and cCtaA from A. pernix
(B). His residues conserved in HAS polypeptides are indicated by dots and denoted as
H1, H2, H3 and H4. Cys residues conserved in bacterial HAS are indicated with ﬁlled
squares and denoted as C1 and C2. Two Cys residues invariant only in CtaA of Bacillus
species are indicated by open squares and denoted as C3 and C4. Residue numbers for
conserved His and Cys in B. subtilis CtaA are provided in Table 3. The positive and
negative sides of the membrane are indicated as + and −, respectively.
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Genes important for mitochondrial heme A synthesis were
originally found by identifying mutations in collections of respiratory
deﬁcient mutants of baker's yeast, S. cerevisiae [43]. The gene for HAS,
COX15, was identiﬁed by the phenotype (i.e., lack of cytochrome a
and heme A), and weak sequence similarity of Cox15p to bacterial
CtaA [44]. A striking difference in the primary sequence of
mitochondrial and bacterial HAS proteins is that the former lacks
the otherwise conserved C1 and C2 Cys residues. COX15 in
Schizosaccharomyces pombe is fused to the YAH1 gene encoding a
mitochondrial ferredoxin. This ﬁnding combined with a number of
experimental results indicates that the heme O to heme A conversion
in mitochondria involves Cox15p, Yah1p and the ferredoxin dehy-
drogenase Arh1p [44,45]. Recently the Trypanosoma cruzi gene for
HAS was identiﬁed by sequence similarity to Cox15p and by the
complementation of a S. cerevisiae COX15 mutant [46].
The human genome contains a gene encoding a yeast Cox15p
homolog. Mutations in this gene have been found in patients with
fatal infantile hypertrophic cardiomyopathy and cause mitochondrial
heme A and cytochrome c oxidase deﬁciency [47]. Interestingly,
mutations in the gene for HOS (COX10) and HAS, respectively,Table 1
Composition of isolated wild-type CtaA/Cox15 from different organisms.
Organism Polypeptide; no. of
residues
Production
host
Heme contenta Refs.
A. pernix cCtaA; 161 E. coli Heme B, heme O,
heme I
[39]
B. stearo-
thermophilus
CtaA; 317 E. coli Heme B, heme A [62]
B. subtilis CtaA; 306 B. subtilis Heme B (≤0.4
mol/mol), heme A
(≤0.2 mol/mol)
[37,40,52]
B. subtilisb Heme B, heme A [52]
E. colib Heme B, heme A [36]
E. colic Heme B (1.95
mol/mol)d
[37]
P. denitriﬁcans CtaA; 391 E. colib Heme B, heme A,
heme O
[63]
Rh. sphaeroides Cox15; 391 E. colib Not reported [66]
a Indicated are major types of heme found in puriﬁed preparations of HAS. The
relative amount of heme types present is inﬂuenced by genetic background and growth
conditions.
b CtaA with a C-terminal hexa-histidyl tag.
c CtaA with a N-terminal hexa-histidyl tag.
d This reported stoichiometry is questionable since protein was determined using
the BCA assay which probably underestimates the CtaA polypeptide content as
discussed before [36].apparently result in very different clinical manifestations in humans
[48,49]. This difference could indicate that the mutations in the two
genes have different levels of penetrance, that heme O accumulation
is toxic, or that heme O plays some function in addition of being
substrate for HAS. Studies in S. cerevisiae indicate that heme O
biosynthesis is positively regulated by heme A biosynthetic in-
termediates or HAS [50] and that transcription of COX10 and COX15
do not share the same regulatory mechanism [51]. Similar inter-
dependence of HOS and HAS and differential gene regulation might
occur also in human cells and contribute to different manifestation of
disease depending on the mutation.
7. Mutant HAS
7.1. His mutants
The spectroscopic features of bacterial HAS suggest bis-histidyl or
perhaps His-Met axial ligation of heme A and heme B (see Section 5.2
and Table 2). The domain organization of the CtaA protein (Fig. 3),
with homologous N- and C-terminal domains and A. pernix cCtaA
being a homo-dimer, might reﬂect that HAS contain two heme
binding sites perhaps with different heme speciﬁcities; one for the
prosthetic group heme B, which presumably is permanently bound,
and one for the substrate, heme O. From available spectroscopic and
heme to protein stoichiometric data it cannot be decided whether
HAS contains one or two heme binding sites [40]. Depending on the
number of heme-binding sites, up to four His residues in the HAS
protein could be involved as axial ligands to heme iron.
The importance of the four conserved His residues in HAS (H1, H2,
H3 an H4) (see Fig. 3) for heme binding and enzyme activity has been
investigated by site-speciﬁc mutagenesis with B. subtilis CtaA. The
mutant variants were produced and studied in two widely different
experimental settings; (i) after heterologous production in E. coli
using a strongly inducible ctaA expression system [37] and (ii) after
homologous overproduction in B. subtilis from ctaA with the native
promoter region [52], respectively (Table 3). Another signiﬁcant
difference between the studies is the placement of the hexa-His tag,
added to facilitate puriﬁcation of protein variants, at opposite ends of
the CtaA polypeptide. One major advantage with analysis in B. subtilis,
compared to in E. coli, is that HAS activity of CtaA variants can be
determined from the assembly of functional cytochrome aa3 (quinol
oxidase) and cytochrome caa3 (cytochrome c oxidase) [52]. These
enzymes can be assayed by spectroscopy and oxidase activity.
Important to note is that this in vivo assay relies on both HAS activity
and incorporation of heme A into oxidase. Activity of B. subtilis CtaA
produced in E. coli can be estimated by the presence of heme I or
heme A formed and remaining bound to the enzyme protein [41]. In
the case of the B. subtilis CtaA mutant study in E. coli [37] wild-type
CtaA contained for unexplained reasons only hemes B and O,
suggesting no enzyme turnover (Table 3). Therefore, although some
isolated mutant variants did contain heme I, the information from E.
coli about HAS activity of several mutants is not conclusive.Table 2
Biophysical features of hemes A and B in isolated B. subtilis CtaA.
Data from references [36,40,53].
Heme A Heme B Refs.
Mid-point redox potential (mV)a +230 + 85 [40]
+168d [53]
EPR spectrum (gmax)b 3.5 3.7 [40]
Alpha band absorption maximum (nm)c 585 559e [36,40]
a At pH 7.
b Oxidized protein at 10 K.
c Reduced protein at room temperature.
d Em of His6-tagged CtaA.
e Split alpha-absorption peak at 77 K with maxima at 553 and 558 nm.
Table 3
Properties of mutant variants of B. subtilis CtaA overproduced in the native bacterium
[52] or heterologously produced in E. coli [37].
CtaA variant Produced in B. subtilisa Produced in E. colib
Activityc Heme contentd Heme contentd
Wild-type ++ B, A B, (O)
Trp39 → Ala B, (O)
Glu57 → Ala B, O
→ Gln B, O
His60 (H1) → Ala B, O
→ Leu − B, O
→ Met + B, (A)
→ Gln B, O
Arg61 → Ala B, (O)
→ Gln B, (O)
Glu103 → Ala B, (O)
His123 (H2) → Ala B, O
→ Leu − B, O
→ Met − B, O
→ Gln B, (O)
H216 (H3) → Alaf B, O, I
→ Leue −
→ Met + B, O, I, (A)
→ Glnf B, O, I
R217 → Ala B, (O), I
→ Gln B, (O), I
Gln257 → Ala B, (O), (I)
H278 (H4) → Alaf B, O
→ Leu + (B), (A)
→ Met + (B), (A)
→ Glnf B, O, I
Cys35 (C1) → Ala +g B, O, (I), (A)g
Cys35 (C1) → Ala −g B, Og B, Of
+
Cys42 (C2) → Ala
Cys191 (C3) → Ala +g B, I, A (O)g B, Of
+
Cys197 (C4) → Ala
a CtaA with a C-terminal His6-tag synthesized in B. subtilis strain LMT20R containing
the ctaA gene with natural promoter on plasmid pHPKS. CtaA was solubilized from
isolated membranes and puriﬁed in the presence of the detergent Thesit.
b CtaA with a N-terminal His6-tag synthesized in E. coli strain BL21 (DE3)/pLys from
ctaA under the IPTG-inducible T7 promoter in plasmid pET-15b. CtaA was solubilized
from isolated cytoplasmic membranes and puriﬁed in the presence of sucrose
monolaurate.
c Activity determined indirectly in vivo in B. subtilis as presence of functional
cytochrome c oxidase (see text for details); ++, wild type activity, + low activity, −
no detectable activity.
d Heme content of isolated protein variant determined using HPLC; small amounts of
heme are indicated with brackets.
e CtaA polypeptide not detectable in membranes.
f CtaA polypeptide partly degraded.
g Results obtained in B. subtilis; A. Lewin and L. Hederstedt, unpublished data.
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in B. subtilis CtaA as essential for HAS activity and H1 and H3 as being
important but replaceable by Met without total loss of activity. HAS
activity was found when H4 was replaced by Leu or Met. Since Met, in
principle, can function in place of His as axial ligand, the combined
ﬁndings indicate H1 and H3 as possible axial ligands to heme. Residues
H1 and H3 have analogous positions in the two homologous halves of
CtaA (Fig. 3). The functional importance of H3 is supported by the
properties of an active B. subtilis CtaA variant lacking a segment
comprising residues 211 to 217, which includes H3 (position 216). In
this truncated variant a non-conserved His residue (at position 209 in
wild-type CtaA) substitutes for the missing H3 [53].
The heme-binding properties of B. subtilis CtaA variants, mutated
in residues that are conserved in HAS proteins, were analyzed by
spectroscopy and heme analysis of the puriﬁed proteins produced in
E. coli or B. subtilis. Results are presented in Table 3. All variants were
found to bind heme B and, with only few exceptions, also heme O.
The enzymatically inactive variants generally contained heme B and
heme O showing that substrate binding and catalytic activity are
separable. Remarkably, H1+H2 (a His60Ala+His123Ala as well as a
His60Gln+H123Gln) double mutants were found to bind heme B to
the same extent as wild-type CtaA [37]. The ﬁndings are consistent
with the presence of two heme binding sites in HAS. This is
supported by the observation [54] that an A. pernix His75Leu mutant
cCtaA (being equivalent to a H1+H3 CtaA double mutant) was
found to bind only heme B whereas a His136Met variant (equivalent
to H2+H4 double mutant) bound heme B and heme O. A His136Leu
cCtaA mutant was found unstable and could therefore not be
analysed.
CtaA mutant variants with low HAS activity and produced in B.
subtilis contained, similar to wild-type and as expected, heme A. Some
variants accumulated the mono-hydroxylated intermediate heme I
(Fig. 2). This was pronounced in His216 (H3) and Arg217 mutant
variants indicating defective enzyme turnover. At present, in the
absence of information about the spatial organization of the eight
TMs of CtaA, the available results (Table 3) [54] do not explain in any
detail the roles of invariant His residues in HAS but suggest two
separate heme bindings sites and that H3 functions as a heme ligand.
7.2. Cys mutant variants
The two conserved Cys (C1 and C2) in the N-terminal half of
bacterial HAS appear important for enzyme function. Substitution of
C1 (Cys35Ala) in B. subtilis resulted in very low enzyme activity
whereas substitution of residue C2 (Cys42Ala) and also a C1 C2
double mutant, respectively, resulted in inactive enzyme as deter-
mined in vivo (Table 3). These three mutant variants were all found
to bind heme B and heme O. The C1 mutant in addition contained a
trace of heme A, consistent with low HAS activity. The two Cys
residues in the C-terminal half of B. subtilis CtaA (C3 and C4) appear
dispensable for function because HAS activity was fully retained in
variants where both these Cys were replaced by Ala (Table 3).
Possible functions of the C1 C2 pair are: (i) As ligands to a hitherto
unrecognized metal ion cofactor, or (ii) to form a disulﬁde bond to
stabilize the enzyme or modulate enzyme activity, or (iii) to mediate
interaction with other proteins of importance for e.g. heme A delivery
to oxidase, or (iv) to have redox function in electron transfer to HAS
similar to what has been observed for bacterial homologues of
vitamin K epoxide reductase [55]. Our recent experiments with A.
pernixwild-type, Cys49Ala, and Cys56Ala cCtaA mutant variants have
demonstrated that an intra-molecular disulﬁde bond (between Cys49
and C56) as well as an inter-molecular disulﬁde bond (between Cys in
the two cCtaA proteins in the homo-dimer) can form in bacterial HAS
[54](A. Lewin and L. Hederstedt, unpublished data). The intermole-
cular disulﬁde cross-link shows proximity of the hydrophilic loops in
the two protein domains in the folded enzyme protein (Fig. 3). Thewild-type cCtaA as isolated contained predominantly intramolecular
disulﬁde bonds. These results suggest the presence of a disulﬁde bond
between C1 and C2 and between C3 and C4 in B. subtilis CtaA. A B.
subtilis CtaA C1+C2 double mutant was found unstable in E. coli [37]
but this was not observed in B. subtilis [54]. The combined
experimental results indicate that a disulﬁde bond between C1 and
C2 is important for activity of bacterial HAS but is not required for
binding heme O. The low activity of the C1 variant could be explained
by the formation of a disulﬁde bond between C2 and C4 partly
substituting for the missing bond between C1 to C2.
8. Chlorophyll b and heme A biosynthesis compared
Cyanobacteria, mosses, ferns and seed plants contain in their light-
harvesting antenna complexes both chlorophyll a and b which only
differ in structure at the C7 side group; chlorophyll a has a methyl
group whereas chlorophyll b has a formyl group at this position.
Biosynthesis of chlorophyll b shows similarities to heme A synthesis
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sion of a methyl group to a formyl group on a cyclic metallo-
polypyrrole compound. It has been demonstrated by 18O-labeling
experiment that the oxygen atom of the chlorophyll b formyl group is
directly derived from dioxygen [56,57]. Chlorophyllide a oxygenase
(CAO) catalyzes monooxygenation of chlorophyllide a to yield
chlorophyllide b which subsequently is converted to chlorophyll b.
The CAO reaction is suggested to contain two reaction intermediates;
a stable monohydroxy-methyl derivative and an unstable dihydroxy-
methyl derivative which converts to a formyl group by the
elimination of water [58]. CAO of Arabidopsis thaliana and Chlamydo-
monas reinhardtii is a 56 and 51 kDa, respectively, chloroplast
membrane bound protein containing a Rieske-type [2Fe–2S] center
and a non-heme iron center [59–61]. The amino acid sequences of
CAO from cyanobacteria and plants are highly conserved [60] and
show similarity to e.g. vanillate demethylase and p-toluenesulfonate
monooxygenase which catalyze oxygenation of a methyl side chain of
an aromatic ring converting it to a hydroxy-methyl group [59]. The
electron donor to CAO is thought to be ferredoxin or possibly
ferredoxin-NADPH reductase directly. Thioredoxin of 14 kDa has
been found to be co-immunoprecipitated with C. reinhardtii CAO but
the signiﬁcance of this is unknown [61].
EPR studies with A. thaliana and C. reinhardtii CAO have shown the
presence of a [2Fe–2S] center (g=2.057 signal detectable at 15 K), a
non-hememono-nuclear iron (g=4.3 signal detectable at 125 K) and a
g=2.0042 signal characteristic of an organic radical species [61]. The
radical was found associatedwith a Tyr residue (Tyr422 in C. reinhardtii
and Tyr518 in A. thaliana) present in a somewhat invariant sequence,
-ValArg/AlaTyrArg-, close to the C-terminal end of the enzyme
polypeptide. The EPR signal of the radical was found to form in the
absence of cognate substrate and being stable, but quenched by
addition of chlorophyll [61]. The ﬁndings together suggest that during
the enzyme reaction the radical is transferred to the substrate and then
reacts with an oxygen complex at the mono-nuclear iron center to
generate the C7 hydroxy-methyl intermediate [61]. The structure and
reaction mechanism of CAO are far from understood and physiological
electron donors/interacting proteins remain to be identiﬁed.
9. On the possible enzyme mechanism of HAS
Studies aiming to elucidate the reaction mechanism of HAS are
currently hampered by the lack of an in vitro enzyme assay system. So
far, HAS activity has not been reported for any preparation of puriﬁed
CtaA. As a lead in the search for assay conditions, HAS activity was
detected in isolated E. coli membranes containing B. stearothermophi-
lus CtaA [62]. Incubation of the membranes in the presence of added
heme O and dithiothreitol yielded, apparently as the result of a single
enzyme turnover, heme A bound to CtaA in the membrane. Under the
same incubation conditions no activity was detected with B.
stearothermophilus CtaA puriﬁed in the presence of the detergent
Triton X-100.
In the absence of an in vitro activity assay for HAS it cannot be
ruled out that one or more essential cofactors are missing in isolated
CtaA. However, with heme B as prosthetic group and no other metal
cofactor available, except the substrate heme O, the catalytic
mechanism of bacterial HAS presumably involves heme iron. As
discussed before [40], the enzyme protein does not show the features
of a P450-type mixed function monooxygenase. Heme B or heme O,
however, probably plays a key role in activation of oxygen for
hydroxylation of the C8 methyl group of heme O. The heme A
biosynthetic reaction comprises two enzyme bound hydroxylated
intermediates; the C8 alcohol (heme I), which is stable, and the
unstable putative C8 geminal diol that dehydrates to form heme A
(Fig. 2). Molecular oxygen is required for HAS activity as concluded
form a multitude of in vivo experiments using oxygen limitation, e.g.,
[41,63]. Under oxygen-limited conditions heme I accumulates and is,if oxygen is supplied, rapidly oxidized to heme A and can to some
extent be over-oxidized to form heme II with a C8 carboxyl group
[64]. Based on these experimental ﬁndings and comparison to
chlorophyll b synthesis (see Section 8) one expects that the formyl
group oxygen atom of heme A is directly derived from atmospheric
molecular oxygen. Brown et al. [64] have, however, presented
compelling evidence that HAS does not incorporate molecular oxygen
into heme A. To rationalize their ﬁndings in the light of biochemical
data with isolated HAS, the authors have proposed heme iron-
dependent mechanisms for the heme O to heme A conversion step
[40,64].
Assuming very similar reaction mechanisms of HAS and CAO it is
interesting that the former is apparently dependent on heme and
catalyses oxygenation of a methyl group on an iron-prophyrin
whereas the latter is a non-heme enzyme catalyzing oxygenation of
a methyl group on a magnesium-porphyrin. In both cases the reaction
probably involves a radical but this has only been shown in the case of
CAO. Generation of a radical in HAS is presumably connected to heme
iron and binding of oxygen. In CAO the Rieske iron–sulfur center and
mono-nuclear iron center are needed because the magnesium ion of
the chlorophyllide is not useful for redox reactions. Ferredoxin (or
ferredoxin reductase) is electron donor to CAO and apparently also to
mitochondrial HAS. How electrons enter bacterial HAS is unknown
but could involve Cys residues C1 and C2 (see Section 7.2). If so, an
extra-cytoplasmic electron donor, such as a thioredoxin-like protein,
would also be involved. TlpA (thioredoxin-like protein A) of
Bradyrhizobium japonicum is required for cytochrome aa3 maturation
but it is not known if this membrane protein is important for heme A
synthesis [65]. Menaquinol in the membrane can reduce heme B (and
heme A) in membrane bound B. subtilis CtaA [36]. This presents
quinol as a potential physiological electron donor to bacterial HAS. To
substantiate this possibility, data regarding kinetics of electron
transfer rates and binding of quinone to CtaA are desired.
10. Outlook — major unresolved questions regarding HAS
10.1. In vitro assay and protein structure
Critical to advances in HAS research is now to establish a deﬁned in
vitro system in which the cofactor dependency of the enzyme can be
identiﬁed and the activity of isolated protein determined. It is relevant to
mention that an in vitro system for CAO activity measurements is
available based on ferredoxin and ferredoxin reductase as electron
donors [58]. HAS research is also restricted by the lack of protein
structural information beyond the trans-membrane topology level
(Fig. 3.) and speculative models on how the TMs might be arranged
relative one another [37,38]. With knowledge about the organization of
TMs in the membrane and the number of heme binding sites, the
available HAS mutant data (Table 3) would be more conclusive.
Attempts in my laboratory to crystallize B. subtilis CtaA and A. pernix
cCtaA have so far beenunsuccessful. Besides the difﬁculty of crystallizing
integral membrane proteins, inhomogeneity of HAS preparations with
regard to heme content and composition poses a problem. Heme-free A.
pernix cCtaA, produced by cell-free protein synthesis in the presence of
detergent and puriﬁed [54], is potentially suitable for crystallization and
useful for other types of experiments concerning HAS.
10.2. Heme trafﬁcking and protein interactions
Only little is known about proteins interacting with HAS in the
membrane and trafﬁcking of heme O and heme A in cells. HOS and
HAS appear to form a complex in the cytoplasmic membrane of
bacteria [66] and probably also in the inner mitochondrial membrane.
Consistent with the existence of such a complex, the HOS and HAS
polypeptides in the bacterium Thermus thermophilus are fused into a
608 residues CtaA–CtaB protein. A complex does not seem important
926 L. Hederstedt / Biochimica et Biophysica Acta 1817 (2012) 920–927for stability of the enzymes but thought to facilitate transfer of heme
O from HOS to HAS. When heme A synthesis overrides the demand
for heme A in the cell, i.e., when active HAS, and especially both HOS
and HAS, is overproduced in the cell heme A remains bound to HAS.
Thus, the release of heme A from HAS seemingly requires interaction
with other proteins. Recently it was demonstrated in vitro with
puriﬁed proteins that P. denitriﬁcans Surf1 proteins interact with heme
A-loaded HAS (CtaA) resulting in the transfer of heme A (but not heme
B) to Surf1 [63]. P. denitriﬁcans contains two Surf1 paralogues, Surf1c
and Surf1q. Both variants showed heme A acceptor activity and
mutation of a conserved Trp residue resulted in a shift in binding
speciﬁcity from heme A to heme O. Surf1 in bacteria and yeast (Shy1p)
are membrane proteins important for proper assembly of functional
cytochrome a, especially the heme a3 prosthetic group [67,68]. The
ﬁndings suggest that binding of Surf1/Shy1p to HAS triggers release of
heme A and that Surf1/Shy1p functions both as heme chaperone and
cytochrome assembly factor. Some functional cytochrome a can
assemble also in the absence of Surf1/Shy1p. This indicates the presence
of additional heme A chaperones or that HAS is able to donate heme A
directly to apo-cytochrome a [63]. Two heme A molecules are needed
for assembly of each cytochrome oxidasemolecule. The incorporation of
these potentially harmful hemes and copper atoms has to be
coordinated with the folding of the Subunit I polypeptide in the
membrane and organized assembly with the other subunits in the
membrane [69,70]. It remains to be investigated howand towhat extent
HAS interacts with structural polypeptides and speciﬁc assembly factors
during biogenesis of respiratory cytochrome a oxidases. For example,
duringmaturation of Subunit I are the two hemeAmolecules for heme a
and heme a3 assembly synthesized on the same HAS enzyme molecule
or are they synthesized and delivered by separate HAS molecules?
10.3. Heme A degradation
Apparently completely unexplored aspects related to heme A
synthesis is whether heme A and heme O are recycled in nature and
how these hemes are degraded in biological systems. Is heme
oxygenase, which normally uses heme B as both cofactor and substrate,
active with modiﬁed hemes? Many bacteria can take up heme B from
the environment and use it for heme protein synthesis or as an iron
source. This could comprise also hemeO and hemeA. Information about
transport of modiﬁed hemes across membranes and uptake by
microorganisms is lacking. B. subtilis cells can take up heme B but a
ctaB deletion mutant can apparently not use heme O in the growth
medium for cytochrome a synthesis (L. Hederstedt, unpublished data).
CAO plays a critical role in the so called “chlorophyll cycle” in plants by
catalyzing oxygenation of chlorophyllide a to chlorophyllide b but also
the reverse reaction. It remains to ﬁnd out if HAS or some other enzyme
in vivo can catalyze reduction of heme A to yield heme O. Several of
these open questions can be experimentally addressed using heme A
and heme O available as pure chemical compounds and suitable well
deﬁned microbial mutants.
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